South African businessman Gus Attridge loses $11.96 million in 24 days
Attridge, Aspen’s group chief advisor, who ranks as one of South Africa’s richest businessmen, owns a 4.26-percent stake in the pharmaceutical holding company.
Aspen Pharmacare
South African billionaire Stephen Saad earns $2-million salary from Aspen in 2023
Apart from his executive and governance roles in Aspen Pharmacare, Saad also holds a controlling 12.5-percent stake in the company.
South African tycoon Gus Attridge loses $7.2 million in 5 days from Aspen stake
Attridge, Aspen’s group chief advisor, who ranks as one of South Africa’s richest businessmen, owns a 4.26-percent stake in the pharmaceutical holding company.
Stephen Saad’s Aspen to pioneer South Africa’s first human insulin production
Established in 1997 by Saad, Aspen has steadily expanded its global presence in the pharmaceutical sector.
South African executive Gus Attridge loses $27.3 million in 43 days
Attridge, Aspen’s group chief advisor, owns a 4.26-percent stake in the pharmaceutical company.
South African billionaire Stephen Saad’s Aspen partners with Eli Lilly to expand medical access
Aspen Pharmacare, founded by Saad in 1997, has steadily fortified its global presence in the pharmaceutical sector for over two decades.
South African executive scores big with $55-million gain from Aspen Pharmacare
South African executive Michael Guy Attridge (Gus Attridge) has witnessed a remarkable year-to-date gain of more than $55 million from his stake in Aspen Pharmacare
5 South Africans who founded billion-dollar pharma companies
Billionaires.Africa shines a spotlight on five South African trailblazers who have propelled South Africa onto the global stage of medical innovation.
Gus Attridge gains $55 million from investment in Aspen
Attridge, Aspen’s group chief advisor who ranks as one of South Africa’s richest businessmen, owns a 4.26-percent stake in the pharma company.
South African billionaire-led firm to snap up Viagra and others for $280 million
Aspen Pharmacare is a branded pharmaceutical company.
South African billionaire Stephen Saad’s Aspen Pharma stake falls by $29 million in 27 days
Saad’s stake in Aspen Pharma has fallen by $29 million as investors factor in the challenging operating conditions in the pharmaceutical industry.
South African billionaire Stephen Saad rakes in $132 million as Aspen shares skyrocket
With a net worth of $1.2 billion, Saad’s 12.5-percent stake in Aspen Pharmacare accounts for a significant portion of his wealth.
South African pharma tycoon Stephen Saad gains $37.1 million from Aspen shares
Saad owns a significant 12.5-percent stake in Aspen Pharmacare Holdings.
South African billionaire Stephen Saad’s Aspen secures $30 million grant to make vaccines
Aspen Pharmacare Holdings Limited is a South African multinational pharmaceutical holding company.
South African exec Gus Attridge loses $10 million in 13 days from stake in Aspen Pharmacare
Attridge owns a 4.26-percent stake in the company.
South African multimillionaire Gus Attridge’s stake in Aspen now worth $171 million
Aspen Pharmacare is a multinational pharmaceutical holding company.